1. |
Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med, 2005, 352(17): 1791-1798.
|
2. |
Dentali F, Poli D, Scoditti U, et al. Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost, 2012, 10(7): 1297-1302.
|
3. |
Miranda B, Ferro JM, Canhao P, et al. Venous thromboembolic events after cerebral vein thrombosis. Stroke, 2010, 41(9): 1901-1906.
|
4. |
Tufano A, Guida A, Coppola A, et al. Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis. Blood Transfus, 2014, 12(Suppl 1): s337-s342.
|
5. |
Voetsch B, Jin RC, Bierl C, et al. Role of promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene as a risk factor for cerebral venous thrombosis. Stroke, 2008, 39(2): 303-307.
|
6. |
Madonna P, De Stefano V, Coppola A, et al. G20210A PRTH gene mutation and other trombophilic polymorphisms in patients with cerebral vein thrombosis. Stroke, 2000, 31(7): 1787-1788.
|
7. |
Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 1996, 88(10): 3698-3703.
|
8. |
常建华, 马越, 张广森. 中国壮族人群凝血酶原基因 G20210A 突变频率研究. 中华医学遗传学杂志, 2005, 12(03): 341-343.
|
9. |
Bank I, Libourel EJ, Middeldorp S, et al. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Arch Intern Med, 2004, 164(17): 1932-1937.
|
10. |
Haywood S, Liesner R, Pindora S, et al. Thrombophilia and first arterial ischaemic stroke: a systematic review. Arch Dis Child, 2005, 90(4): 402-405.
|
11. |
Cosmi B, Legnani C, Pengo V, et al. The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs. Thromb Haemost, 2013, 109(3): 510-516.
|
12. |
Margaglione M, Brancaccio V, De Lucia D, et al. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest, 2000, 118(5): 1405-1411.
|
13. |
De Stefano V, Martinelli I, Mannucci PM, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med, 1999, 341(11): 801-806.
|
14. |
Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. A meta-analysis involving approximately 120 000 cases and 180 000 controls. Thromb Haemost, 2009, 102(2): 360-370.
|
15. |
Jiang B, Ryan KA, Hamedani A, et al. Prothrombin G20210A mutation is associated with young-onset stroke: the genetics of early-onset stroke study and meta-analysis. Stroke, 2014, 45(4): 961-967.
|
16. |
Altinisik J, Ates O, Ulutin T, et al. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients. Clin Appl Thromb Hemost, 2008, 14(4): 415-420.
|
17. |
Ben SO, Fekih-Mrissa N, N’Siri B, et al. Thrombophilic polymorphisms-factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis. J Clin Neurosci, 2012, 19(9): 1326-1327.
|
18. |
Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol, 2002, 70(2): 126-132.
|
19. |
Boncoraglio G, Carriero MR, Chiapparini L, et al. Hyperhomocysteinemia and other thrombophilic risk factors in 26 patients with cerebral venous thrombosis. Eur J Neurol, 2004, 11(6): 405-409.
|
20. |
Bonduel M, Sciuccati G, Hepner M, et al. Arterial ischemic stroke and cerebral venous thrombosis in children: a 12-year Argentinean registry. Acta Haematol, 2006, 115(3-4): 180-185.
|
21. |
Colaizzo D, Amitrano L, Iannaccone L, et al. Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings. J Med Genet, 2007, 44(6): 412-416.
|
22. |
Heller C, Heinecke A, Junker R, et al. Cerebral venous thrombosis in children: a multifactorial origin. Circulation, 2003, 108(11): 1362-1367.
|
23. |
Kenet G, Waldman D, Lubetsky A, et al. Paediatric cerebral sinus vein thrombosis. A multi-center, case-controlled study. Thromb Haemost, 2004, 92(4): 713-718.
|
24. |
Klai S, Fekih-Mrissa N, Mrissa R, et al. Maternal cerebral venous thrombosis, uncommon but serious disorder, pathologic predictors and contribution of prothrombotic abnormalities. Blood Coagul Fibrinolysis, 2013, 24(3): 269-272.
|
25. |
Le Cam-Duchez V, Bagan-Triquenot A, Menard JF, et al. Association of the protein C promoter CG haplotype and the factor II G20210A mutation is a risk factor for cerebral venous thrombosis. Blood Coagul Fibrinolysis, 2005, 16(7): 495-500.
|
26. |
Le Cam-Duchez V, Bagan-Triquenot A, Barbay V, et al. The G79A polymorphism of protein Z gene is an independent risk factor for cerebral venous thrombosis. J Neurol, 2008, 255(10): 1521-1525.
|
27. |
Lichy C, Dong-Si T, Reuner K, et al. Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems. J Neurol, 2006, 253(3): 316-320.
|
28. |
Lichy C, Kloss M, Reismann P, et al. No evidence for plasminogen activator inhibitor 1 4G/4G genotype as risk factor for cerebral venous thrombosis. J Neurol, 2007, 254(8): 1124-1125.
|
29. |
Madonna P, De Stefano V, Coppola A, et al. G20210A PRTH gene mutation and other trombophilic polymorphisms in patients with cerebral vein thrombosis. Stroke, 2000, 31(7): 1787-1788.
|
30. |
Margaglione M, Brancaccio V, Ciampa A, et al. Inherited thrombophilic risk factors in a large cohort of individuals referred to Italian thrombophilia centers: distinct roles in different clinical settings. Haematologica, 2001, 86(6): 634-639.
|
31. |
Martinelli I, Sacchi E, Landi G, et al. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med, 1998, 338(25): 1793-1797.
|
32. |
Miller SP, Wu YW, Lee J, et al. Candidate gene polymorphisms do not differ between newborns with stroke and normal controls. Stroke, 2006, 37(11): 2678-2683.
|
33. |
Ozyurek E, Balta G, Degerliyurt A, et al. Significance of factor V, prothrombin, MTHFR, and PAI-1 genotypes in childhood cerebral thrombosis. Clin Appl Thromb Hemost, 2007, 13(2): 154-160.
|
34. |
Rahimi Z, Mozafari H, Bigvand AH, et al. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden. Clin Appl Thromb Hemost, 2010, 16(4): 430-434.
|
35. |
Reuner KH, Ruf A, Grau A, et al. Prothrombin gene G20210-->A transition is a risk factor for cerebral venous thrombosis. Stroke, 1998, 29(9): 1765-1769.
|
36. |
Ringelstein M, Jung A, Berger K, et al. Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults. J Neurol, 2012, 259(11): 2287-2292.
|
37. |
Romero A, Marco P, Verdu J, et al. Genetic thrombophilia and cerebral venous thrombosis. Med Clin Barc, 2007, 128(17): 655-656.
|
38. |
Stolz E, Valdueza JM, Grebe M, et al. Anemia as a risk factor for cerebral venous thrombosis? An old hypothesis revisited. Results of a prospective study. J Neurol, 2007, 254(6): 729-734.
|
39. |
Tufano A, Coppola A, Varricchione N, et al. Predisposing factors in patients with early-onset cerebral vein thrombosis. Thromb Res, 2005, 115(5): 439-440.
|
40. |
Tufano A, Guida A, Coppola A, et al. Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis. Blood Transfus, 2014, 12(Suppl 1): s337-s342.
|
41. |
Ventura P, Cobelli M, Marietta M, et al. Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis. Cerebrovasc Dis, 2004, 17(2-3): 153-159.
|
42. |
孟强. 脑静脉血栓形成的病因学研究. 北京: 军医进修学院, 2001.
|
43. |
白春梅, 潘家绮, 李秀荣, 等. 静脉血栓患者和正常人凝血因子 V Leiden 和凝血酶原基因 G20210A 变异的研究. 中华医学杂志, 1999, 79(12): 19-21.
|
44. |
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med, 2002, 21(11): 1539-1558.
|
45. |
Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ, 2003, 327(7414): 557-560.
|
46. |
Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials, 1986, 7(3): 177-188.
|
47. |
Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol, 2007, 6(2): 162-170.
|
48. |
林雪, 陈军, 赵益林. 脑静脉窦血栓形成的临床和影像学表现. 中华临床医师杂志(电子版), 2012, 6(20): 6325-6329.
|
49. |
Saposnik G, Barinagarrementeria F, Brown RJ, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2011, 42(4): 1158-1192.
|
50. |
Aznar J, Mira Y, Vaya A, et al. Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke. Thromb Haemost, 2004, 91(5): 1031-1034.
|
51. |
Lopaciuk S, Bykowska K, Kwiecinski H, et al. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetra-hydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost, 2001, 7(4): 346-350.
|
52. |
周荣富, 王鸿利. 凝血因子与静脉血栓形成. 国外医学, 输血及血液学分册, 2004, 8(6): 508-512.
|
53. |
郑红, 连建华, 贺颖, 等. 中国人群凝血酶原FⅡG20210A 和 FVLeiden的分布. 郑州大学学报(医学版), 2006, 24(1): 102-104.
|
54. |
Rosendaal FR, Doggen CJ, Zivelin A, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost, 1998, 79(4): 706-708.
|